SE0104203D0 - Farmaceutiska formuleringar och metoder innefattande intranasalt morfin - Google Patents

Farmaceutiska formuleringar och metoder innefattande intranasalt morfin

Info

Publication number: SE0104203D0
Authority: SE; Sweden
Prior art keywords: morphine; pharmaceutical formulations; methods involving; pharmaceutically acceptable; intranasal morphine
Prior art date: 1999-06-16

Application number

SE0104203A

Other languages

English (en)

Swedish (sv)

Other versions

SE0104203L (sv

Inventor

Raja G Achari

Charanjit R Behl

Jorge C Demeireles

Ramneik Dua

Anthoney P Sileno

Vincent D Romeo

Original Assignee

Nastech Pharm Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

2001-12-14

Publication date

2001-12-14

2001-12-14 Application filed by Nastech Pharm Co filed Critical Nastech Pharm Co

2001-12-14 Publication of SE0104203L publication Critical patent/SE0104203L/

2001-12-14 Publication of SE0104203D0 publication Critical patent/SE0104203D0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SE0104203A 1999-06-16 2001-12-14 Farmaceutiska formuleringar och metoder innefattande intranasalt morfin SE0104203D0 (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33453799A	1999-06-16	1999-06-16
PCT/US2000/014157 WO2000076506A1 (en)	1999-06-16	2000-05-23	Pharmaceutical formulations and methods comprising intranasal morphine

Publications (2)

Publication Number	Publication Date
SE0104203L SE0104203L (sv)	2001-12-14
SE0104203D0 true SE0104203D0 (sv)	2001-12-14

Family

ID=23307687

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0104203A SE0104203D0 (sv)	1999-06-16	2001-12-14	Farmaceutiska formuleringar och metoder innefattande intranasalt morfin

Country Status (30)

Country	Link
US (1)	US6677346B1 (fi)
EP (2)	EP1183027A4 (fi)
JP (1)	JP2003501467A (fi)
KR (1)	KR20020016831A (fi)
AU (1)	AU774175B2 (fi)
BG (1)	BG106221A (fi)
BR (1)	BR0012082A (fi)
CA (1)	CA2374877C (fi)
CZ (1)	CZ20014399A3 (fi)
DE (1)	DE10084709T1 (fi)
DK (1)	DK200101859A (fi)
EE (1)	EE200100677A (fi)
ES (1)	ES2197792B1 (fi)
FI (1)	FI20012462L (fi)
GB (1)	GB2367005A (fi)
HR (1)	HRP20010926A2 (fi)
HU (1)	HUP0201856A3 (fi)
IS (1)	IS6202A (fi)
LT (1)	LT4976B (fi)
LU (1)	LU90859B1 (fi)
LV (1)	LV12859B (fi)
MX (1)	MXPA01012879A (fi)
NO (1)	NO20015931L (fi)
NZ (1)	NZ515783A (fi)
PL (1)	PL352556A1 (fi)
SE (1)	SE0104203D0 (fi)
SI (1)	SI20850A (fi)
SK (1)	SK18172001A3 (fi)
TR (1)	TR200103613T2 (fi)
WO (1)	WO2000076506A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9924797D0 (en)	1999-10-20	1999-12-22	West Pharm Serv Drug Res Ltd	Compound
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
US20060083691A1 (en) *	2000-05-10	2006-04-20	Wermeling Daniel P	Intranasal opioid compositions, delivery devices and methods of using same
WO2002024116A1 (en) *	2000-09-20	2002-03-28	Shahinian, Lee, Jr.	Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
EP1418862A4 (en) *	2001-06-29	2010-06-09	Leon J Lewandowski	INDIVIDUALIZED SEARCH THERAPY
GB0210264D0 (en) *	2002-05-03	2002-06-12	Arakis Ltd	The treatment of pain and migraine headache
US20040102476A1 (en) *	2002-11-25	2004-05-27	Chan Tai Wah	High concentration formulations of opioids and opioid derivatives
US20050175679A1 (en) *	2004-02-10	2005-08-11	Michael Moshman	Controlled release formulations
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
PT2486942T (pt)	2004-11-24	2019-01-18	Meda Pharmaceuticals Inc	Composições que compreendem azelastina e seus métodos de utilização
US9415034B2 (en) *	2005-01-05	2016-08-16	National Defense Medical Center	Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
ES2277743B2 (es) *	2005-06-02	2008-12-16	Universidade De Santiago De Compostela	Nanoparticulas que comprenden quitosano y ciclodextrina.
WO2007025286A2 (en) *	2005-08-26	2007-03-01	The Board Of Trustees Of The Leland Stanford Junior University	Therapy procedure for drug delivery for trigeminal pain
US20070212307A1 (en) *	2006-02-10	2007-09-13	Daniel Wermeling	Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
KR101433152B1 (ko) *	2006-12-22	2014-08-22	시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.	안과용 약물의 전달에 유용한 젤
GB2477545B (en) *	2010-02-05	2011-12-21	Special Products Ltd	A liquid morphine composition for buccal administration
SG194927A1 (en)	2011-05-13	2013-12-30	Euro Celtique Sa	Intranasal pharmaceutical dosage forms comprising naloxone
US20150231130A1 (en)	2012-07-26	2015-08-20	Wockhardt Limited	Pharmaceutical composition comprising diamorphine for intranasal administration
EP3082817A4 (en) *	2013-12-18	2017-06-21	Aegis Therapeutics, LLC	Compositions for drug administration
US11135155B2 (en)	2014-07-08	2021-10-05	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
WO2016112205A1 (en)	2015-01-07	2016-07-14	Trigemina, Inc.	Magnesium-containing oxytocin formulations and methods of use
EP4541348A3 (en)	2016-04-12	2025-06-04	Tonix Pharma Limited	Magnesium-containing oxytocin formulations and methods of use
CA3041308A1 (en) *	2016-10-21	2018-04-26	Somniferum Labs LLC	Method, system and apparatus for controlled delivery of opioid and other medications
CA3077627A1 (en) *	2017-10-20	2019-04-25	Chiesi Farmaceutici S.P.A.	Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof
JP6941224B2 (ja)	2018-02-06	2021-09-29	イージスセラピューティクス，エルエルシー	疾患の処置のための鼻腔内エピネフリン製剤及び方法
CN115804754A (zh) *	2022-12-16	2023-03-17	广州新济药业科技有限公司	吗啡鼻喷剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4464378A (en)	1981-04-28	1984-08-07	University Of Kentucky Research Foundation	Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4464376A (en)	1982-07-22	1984-08-07	Richardson-Vicks, Inc.	Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB8514665D0 (en) *	1985-06-11	1985-07-10	Eroceltique Sa	Oral pharmaceutical composition
US5202128A (en)	1989-01-06	1993-04-13	F. H. Faulding & Co. Limited	Sustained release pharmaceutical composition
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
DK0689438T3 (da) *	1993-03-26	2003-09-29	Franciscus Wilhelmus He Merkus	Farmaceutiske præparater til intranasal administration af apomorfin
GB9426102D0 (en)	1994-12-23	1995-02-22	Merck Sharp & Dohme	Pharmacuetical compositions
WO1998013001A1 (en) *	1996-09-27	1998-04-02	Nastech Pharmaceutical Company, Inc.	Intranasal formulations for promoting sleep and method of using the same

2000
- 2000-05-23 JP JP2001502839A patent/JP2003501467A/ja active Pending
- 2000-05-23 MX MXPA01012879A patent/MXPA01012879A/es unknown
- 2000-05-23 CZ CZ20014399A patent/CZ20014399A3/cs unknown
- 2000-05-23 PL PL00352556A patent/PL352556A1/xx not_active Application Discontinuation
- 2000-05-23 SK SK1817-2001A patent/SK18172001A3/sk unknown
- 2000-05-23 ES ES200150086A patent/ES2197792B1/es not_active Expired - Lifetime
- 2000-05-23 HR HR20010926A patent/HRP20010926A2/hr not_active Application Discontinuation
- 2000-05-23 KR KR1020017016009A patent/KR20020016831A/ko not_active Ceased
- 2000-05-23 FI FI20012462A patent/FI20012462L/fi not_active IP Right Cessation
- 2000-05-23 GB GB0128383A patent/GB2367005A/en not_active Withdrawn
- 2000-05-23 AU AU51561/00A patent/AU774175B2/en not_active Ceased
- 2000-05-23 EE EEP200100677A patent/EE200100677A/xx unknown
- 2000-05-23 EP EP00936212A patent/EP1183027A4/en not_active Withdrawn
- 2000-05-23 CA CA002374877A patent/CA2374877C/en not_active Expired - Fee Related
- 2000-05-23 SI SI200020030A patent/SI20850A/sl not_active IP Right Cessation
- 2000-05-23 BR BR0012082-0A patent/BR0012082A/pt not_active IP Right Cessation
- 2000-05-23 TR TR2001/03613T patent/TR200103613T2/xx unknown
- 2000-05-23 NZ NZ515783A patent/NZ515783A/en unknown
- 2000-05-23 EP EP04001252A patent/EP1419774A1/en not_active Withdrawn
- 2000-05-23 WO PCT/US2000/014157 patent/WO2000076506A1/en not_active Ceased
- 2000-05-23 DE DE10084709T patent/DE10084709T1/de not_active Ceased
- 2000-05-23 HU HU0201856A patent/HUP0201856A3/hu unknown
- 2000-06-15 US US09/594,916 patent/US6677346B1/en not_active Expired - Fee Related
2001
- 2001-12-04 NO NO20015931A patent/NO20015931L/no not_active Application Discontinuation
- 2001-12-12 DK DK200101859A patent/DK200101859A/da not_active Application Discontinuation
- 2001-12-13 LT LT2001119A patent/LT4976B/lt not_active IP Right Cessation
- 2001-12-13 LU LU90859A patent/LU90859B1/en active
- 2001-12-14 IS IS6202A patent/IS6202A/is unknown
- 2001-12-14 SE SE0104203A patent/SE0104203D0/xx not_active Application Discontinuation
- 2001-12-14 BG BG106221A patent/BG106221A/xx unknown
2002
- 2002-01-18 LV LVP-01-169A patent/LV12859B/en unknown

Also Published As

Publication number	Publication date
US6677346B1 (en)	2004-01-13
DK200101859A (da)	2001-12-12
EP1183027A4 (en)	2003-02-05
WO2000076506A1 (en)	2000-12-21
TR200103613T2 (tr)	2004-08-23
JP2003501467A (ja)	2003-01-14
CZ20014399A3 (cs)	2002-06-12
LT4976B (lt)	2002-12-30
CA2374877C (en)	2004-04-13
MXPA01012879A (es)	2003-06-24
IS6202A (is)	2001-12-14
HRP20010926A2 (en)	2003-04-30
AU774175B2 (en)	2004-06-17
FI20012462A7 (fi)	2002-01-16
NZ515783A (en)	2004-05-28
SI20850A (sl)	2002-10-31
BR0012082A (pt)	2002-05-07
SE0104203L (sv)	2001-12-14
AU5156100A (en)	2001-01-02
ES2197792A1 (es)	2004-01-01
KR20020016831A (ko)	2002-03-06
BG106221A (bg)	2002-08-30
GB2367005A (en)	2002-03-27
PL352556A1 (en)	2003-08-25
GB0128383D0 (en)	2002-01-16
LU90859B1 (en)	2002-01-24
EE200100677A (et)	2003-02-17
FI20012462L (fi)	2002-01-16
HUP0201856A1 (en)	2002-09-28
CA2374877A1 (en)	2000-12-21
NO20015931D0 (no)	2001-12-04
LV12859B (en)	2002-12-20
SK18172001A3 (sk)	2002-07-02
EP1419774A1 (en)	2004-05-19
LT2001119A (en)	2002-07-25
NO20015931L (no)	2002-02-08
ES2197792B1 (es)	2005-05-01
HUP0201856A3 (en)	2004-12-28
DE10084709T1 (de)	2002-09-26
EP1183027A1 (en)	2002-03-06

Publication	Publication Date	Title
SE0104203L (sv)	2001-12-14	Farmaceutiska formuleringar och metoder innefattande intranasalt morfin
WO2002042462A3 (en)	2003-06-19	Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
MA27265A1 (fr)	2005-04-01	Formulations d'agoniste opioide a antagoniste liberable et sequestre
DK1341542T3 (da)	2007-09-03	Indanylderivater til behandling af luftvejssygdomme
WO2000021515A3 (en)	2000-09-28	Intranasal codeine for the rapid suppression of cough and rapid relief of pain
ITMI912024A1 (it)	1993-01-22	Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
ID29181A (id)	2001-08-09	Kombinasi formoterol dan garam tiotropium
ATE330589T1 (de)	2006-07-15	Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
DK1156790T3 (da)	2003-09-29	Kombinationer af formoterol og motetason furat
PL312683A1 (en)	1996-08-19	Pharmaceutical solutions free of organic salts for nasal administration
DE69824313D1 (de)	2004-07-08	Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
FI20002239L (fi)	2002-04-12	Menetelmä ja laitteisto potilaan pään alueen kuvaamiseksi
ITTO20020102A1 (it)	2003-08-06	Procedimento per la preparazione dell'acido ursodesossicolico disolfato e suoi sali farmaceuticamente accettabili.
DK1105132T3 (da)	2003-11-24	Anvendelse af R(+)-G(A)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorphenyl)ethyl]-4-piperidinemethanol til behandling af obstruktiv søvnapnø
EE200300555A (et)	2004-02-16	Morfiini sisaldav farmatseutiline preparaat ninasiseseks manustamiseks ning meetod valuvaigistava või tuimastava reaktsiooni esilekutsumiseks imetajal

Legal Events

Date	Code	Title	Description
2004-10-19	NAV	Patent application has lapsed